Serine Endopeptidase Stabilization via Additive Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Serine endopeptidases, such as blood clotting factors, are inherently unstable, making it challenging to maintain their activity over time in liquid preparations, especially at room temperature or refrigerated conditions, which is problematic for therapeutic and diagnostic applications.
Innovation Solution
Incorporating additives like ammonium acetate, polyamino acids, glycerol, and specific amino acids (aspartic acid, glutamic acid, histidine, and glycine) into serine endopeptidase preparations to enhance stability, allowing for longer shelf life and improved storage conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If serine endopeptidases are stored under refrigerated conditions or freeze-dried, then their stability and shelf life are improved, but their biological activity and ease of operation are reduced
Solution Approach 1:
The patent applies parameter changes by modifying the chemical composition parameters of the storage medium. Specifically, it identifies optimal concentration ranges for stabilizing agents (0.1-10% w/v), buffering agents (10-100 mM), and excipients, transforming the storage system from requiring extreme conditions to maintaining stability at physiological temperatures through controlled chemical parameters.
Solution Approach 2:
The patent introduces intermediary substances that mediate between the enzyme and the storage environment. Stabilizing agents such as glycerol, sugars, and amino acids act as intermediaries that protect the enzyme from denaturation and degradation, allowing the enzyme to maintain stability without requiring extreme storage conditions.
2Stability of the object's composition
If stabilizing agents are added to protein formulations, then stability is improved, but contamination risk and analysis complexity increase
Solution Approach 1:
The patent applies parameter changes by selecting stabilizing agents with specific physicochemical properties that minimize contamination risk. It optimizes concentrations of glycerol, sugars, and amino acids to provide stabilization while maintaining compatibility with subsequent analytical procedures, thereby reducing the harmful effects of additive contamination.
Solution Approach 2:
The patent employs stabilizing agents that are chemically simple and do not introduce complex biological contaminants. By using small molecules like glycerol, sugars, and amino acids rather than complex proteins or sera, the system achieves stabilization without the contamination risks associated with biologically active materials.
3Stability of the object's composition
If large amounts of albumins are added for stabilization, then stability is improved, but subsequent physicochemical analysis is precluded
Solution Approach 1:
The patent applies parameter changes by controlling the concentration and type of stabilizing agents to levels and compositions that do not interfere with analytical measurements. It specifies optimal concentrations of glycerol, sugars, and amino acids that provide stabilization while maintaining compatibility with spectrophotometric, chromatographic, and electrophoretic analyses.
Solution Approach 2:
The patent extracts the essential stabilization function from complex protein-based stabilizers and implements it through simpler small molecules. By replacing or supplementing albumins with glycerol, sugars, and amino acids, the system maintains stabilization benefits while eliminating the analytical interference caused by large protein additives.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The addition of these additives significantly increases the stability of serine endopeptidases, extending their activity and reducing degradation, as demonstrated by stability studies under accelerated stress conditions, with the Arrhenius equation predicting enhanced stability at lower temperatures.
Implementation Method 1
The goal of the stabilization strategies is essentially to avoid denaturation of the protein. By stabilizing a protein molecule or a preparation containing protein molecules, the protein chemist understands the prevention of conformational changes within the protein molecule. Stabilization consequently leads to the preservation of the native structure and thus also to the preservation of biological activity.
Implementation Method 2
Losses of activity due to physical effects such as adsorption, denaturation through surfaces, heat denaturation, drying, repeated freezing and thawing can often be significantly reduced by adding glycerol, carbohydrates, amino acids, hydrophilic polymers or inert proteins.
Implementation Method 3
This phenomenon is described mathematically and physically using the Arrhenius equation, according to which the temperature dependence of the reaction rate is an exponential function.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Preparation (A) comprises at least a serine endopeptidase; ammonium acetate; at least a polyamino acid; glycerin; and at least an amino acid of asparagine and their salts, glutamic acid and their salts, histidine and glycine.